Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study
- PMID: 33370467
- PMCID: PMC8005428
- DOI: 10.1111/jon.12828
Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study
Abstract
Background and purpose: To determine the ability of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict long-term response of brain metastases prior to and within 72 hours of stereotactic radiosurgery (SRS).
Methods: In this prospective pilot study, multiple b-value DWI and T1-weighted DCE-MRI were performed in patients with brain metastases before and within 72 hours following SRS. Diffusion-weighted images were analyzed using the monoexponential and intravoxel incoherent motion (IVIM) models. DCE-MRI data were analyzed using the extended Tofts pharmacokinetic model. The parameters obtained with these methods were correlated with brain metastasis outcomes according to modified Response Assessment in Neuro-Oncology Brain Metastases criteria.
Results: We included 25 lesions from 16 patients; 16 patients underwent pre-SRS MRI and 12 of 16 patients underwent both pre- and early (within 72 hours) post-SRS MRI. The perfusion fraction (f) derived from IVIM early post-SRS was higher in lesions demonstrating progressive disease than in lesions demonstrating stable disease, partial response, or complete response (q = .041). Pre-SRS extracellular extravascular volume fraction, ve , and volume transfer coefficient, Ktrans , derived from DCE-MRI were higher in nonresponders versus responders (q = .041).
Conclusions: Quantitative DWI and DCE-MRI are feasible imaging methods in the pre- and early (within 72 hours) post-SRS evaluation of brain metastases. DWI- and DCE-MRI-derived parameters demonstrated physiologic changes (tumor cellularity and vascularity) and offer potentially useful biomarkers that can predict treatment response. This allows for initiation of alternate therapies within an effective time window that may help prevent disease progression.
Keywords: Brain metastases; DCE-MRI; DWI; stereotactic radiosurgery; treatment response.
© 2020 American Society of Neuroimaging.
Figures




Similar articles
-
Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.J Neurooncol. 2017 Oct;135(1):119-127. doi: 10.1007/s11060-017-2556-z. Epub 2017 Jul 1. J Neurooncol. 2017. PMID: 28669014
-
Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.AJR Am J Roentgenol. 2018 Jul;211(1):168-175. doi: 10.2214/AJR.17.18890. Epub 2018 Apr 30. AJR Am J Roentgenol. 2018. PMID: 29708785
-
Predictive value of early DCE and DSC perfusion MRI parameters for midterm clinical outcomes in lung cancer brain metastases treated with stereotactic radiosurgery.J Neurooncol. 2025 Aug;174(1):207-218. doi: 10.1007/s11060-025-05054-5. Epub 2025 May 23. J Neurooncol. 2025. PMID: 40408063 Free PMC article.
-
The emerging potential of quantitative MRI biomarkers for the early prediction of brain metastasis response after stereotactic radiosurgery: a scoping review.Quant Imaging Med Surg. 2023 Feb 1;13(2):1174-1189. doi: 10.21037/qims-22-412. Epub 2023 Jan 2. Quant Imaging Med Surg. 2023. PMID: 36819250 Free PMC article.
-
Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X).Br J Radiol. 2023 Dec;96(1152):20220462. doi: 10.1259/bjr.20220462. Epub 2023 Oct 24. Br J Radiol. 2023. PMID: 37660364 Free PMC article. Review.
Cited by
-
Quantitative Relaxometry Metrics for Brain Metastases Compared to Normal Tissues: A Pilot MR Fingerprinting Study.Cancers (Basel). 2022 Nov 15;14(22):5606. doi: 10.3390/cancers14225606. Cancers (Basel). 2022. PMID: 36428699 Free PMC article.
-
Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery.Phys Imaging Radiat Oncol. 2024 Jun 24;31:100602. doi: 10.1016/j.phro.2024.100602. eCollection 2024 Jul. Phys Imaging Radiat Oncol. 2024. PMID: 39040435 Free PMC article.
-
Quantitative Synthetic Magnetic Resonance Imaging for Brain Metastases: A Feasibility Study.Cancers (Basel). 2022 May 27;14(11):2651. doi: 10.3390/cancers14112651. Cancers (Basel). 2022. PMID: 35681631 Free PMC article.
-
A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology.Tomography. 2023 Nov 3;9(6):2052-2066. doi: 10.3390/tomography9060161. Tomography. 2023. PMID: 37987347 Free PMC article.
-
Radiological Biomarkers for Brain Metastases Prognosis: Quantitative Magnetic Resonance Imaging (MRI) Modalities As Non-invasive Biomarkers for the Effect of Radiotherapy.Cureus. 2023 Apr 30;15(4):e38353. doi: 10.7759/cureus.38353. eCollection 2023 Apr. Cureus. 2023. PMID: 37266043 Free PMC article. Review.
References
-
- Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep 2012;14:48–54. - PubMed
-
- Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Goncalves A. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 2012;32:4655–62. - PubMed
-
- Koffer P, Chan J, Rava P, et al. Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 2017;104:589–93. - PubMed
-
- Sharpton SR, Oermann EK, Moore DT, et al. The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications. Neurosurgery 2014;74:9–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical